INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG)
BMC CANCER. Bd. 23. H. 1. 2023
Erscheinungsjahr: 2023
Publikationstyp: Zeitschriftenaufsatz
| Geprüft | Bibliothek |
Autoren
Lam, Lyn Ley (Autor)
Pavlakis, Nick (Autor)
Shitara, Kohei (Autor)
Sjoquist, Katrin M. (Autor)
Martin, Andrew J. (Autor)
Yip, Sonia (Autor)
Kang, Yoon-Koo (Autor)
Bang, Yung-Jue (Autor)
Chen, Li-Tzong (Autor)
Moehler, Markus (Autor)
Bekaii-Saab, Tanios (Autor)
Alcindor, Thierry (Autor)
O'Callaghan, Christopher J. (Autor)
Tebbutt, Niall C. (Autor)
Hague, Wendy (Autor)
Chan, Howard (Autor)
Rha, Sun Young (Autor)
Lee, Keun-Wook (Autor)
Gebski, Val (Autor)
Jaworski, Anthony (Autor)
Zalcberg, John (Autor)
Price, Timothy (Autor)
Simes, John (Autor)
Goldstein, David (Autor)
Klassifikation
DDC Sachgruppe:
Medizin
